Table 1.
Subject demographic and baseline characteristics.
| Variable | Subjects (N = 25) |
|---|---|
| Age (years) | |
| Mean (s.d.) | 10·4 (3·84) |
| Median (range) | 11 (3–16) |
| Subjects in each age group, n (%) | |
| 2–5 years | 3 (12·0) |
| 6–11 years | 12 (48·0) |
| 12–16 years | 10 (40·0) |
| Gender, n (%) | |
| Male | 19 (76·0) |
| Female | 6 (24·0) |
| Diagnosis, n (%) | |
| Common variable immunodeficiency | 22 (88·0) |
| X‐linked and autosomal forms of agammaglobulinaemia | 3 (12·0) |
| Subjects with infection(s) related to prior IVIG therapy in past 6 months, n (%) | |
| 0 infections | 7 (28·0) |
| 1 infection | 7 (28·0) |
| 2 infections | 5 (20·0) |
| 3 infections | 4 (16·0) |
| ≥ 4 infections | 2 (8·0) |
| Ongoing infections, n (%) | 3 (12·0) |
IVIG = intravenous immunoglobulin; s.d. = standard deviation.